Real-world evidence to support health technology assessment and payer decision making: is it now or never?
High-quality, fit-for-purpose RWD/RWE can and should be used more frequently in HTA. Multi-stakeholder and cross-geography collaborative partnerships are needed to align on best practices to optimize the evidence that needs to be generated to satisfy all stakeholders' needs.
Authors
- Ron Akehurst
- Oriol Solà-Morales (ORCID: https://orcid.org/0000-0002-8312-8178)
- Gérard de Pouvourville (ORCID: https://orcid.org/0000-0002-5941-6823)
- David Cunningham
- Linda A Murphy (ORCID: https://orcid.org/0009-0002-0891-2234)
Institutions
- École Supérieure des Sciences Économiques et Commerciales (FR)
Publication Details
- Journal
- International Journal of Technology Assessment in Health Care
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1017/s0266462325000145
- Citations
- 2
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 6.26
Funders
- Novartis